Skip to main content
Signal8

PR Newswire press releases

Full-text press releases distributed by PR Newswire, newest first. Times are US Eastern.

Source: PR Newswire

  1. Allenby Cosmetic Dermatology Partners with Aviva Aesthetics, Bringing the Platform to Florida

    Aviva Aesthetics, the only entrepreneur-owned national platform built for medical aesthetics practice owners, today announced that Allenby Cosmetic Dermatology, founded by board-certified dermatologist Dr. Janet Allenby, has joined its growing network of practice partners. The partnership marks Aviva's first practice location in Florida and expands the platform's presence into one of the country's most established aesthetics markets.

  2. Judy Torres Shares Her Life Beyond the Spotlight in No Reason to Cry: A Memoir

    For decades, audiences have known Judy Torres through her voice. In No Reason to Cry: A Memoir, the singer and New York radio personality invites them to know her story.

  3. Lubbock Plastic Surgeon Dr. Thanapoom Boonipat Leads Suturing Workshop for Texas Tech Women in STEM Premed Students

    Dr. Thanapoom "Mo" Boonipat, plastic surgeon and founder of FacePlus Plastic Surgery Institute in Lubbock, led a hands-on suturing workshop and career Q&A session for premed students at Texas Tech University. The event was organized by Women in STEM at Texas Tech University. During the workshop, students practiced suturing fundamentals on suture pads using surgical instruments, with Dr. Boonipat demonstrating technique and coaching students individually. The session also included an open discussion about the path to a career in medicine, including medical school, residency training, and choosing a surgical specialty. "Every surgeon remembers the first time they held a needle driver. Giving premed students that experience early — along with honest answers about the road ahead — can make the path into medicine feel real and reachable. I was glad to spend the afternoon with such motivated students." — Dr. Thanapoom Boonipat "Organizations like Women in STEM do important work connecting young women with mentors and hands-on experience in fields where they are still underrepresented, including surgery. FacePlus is proud to support that effort here in our own community in Lubbock." — Dr. Thanapoom Boonipat Women in STEM is a Texas Tech University student organization that supports women pursuing undergraduate and graduate studies in science, technology, engineering and mathematics. Events like this connect students with practicing professionals and give them early, practical exposure to clinical skills. Dr. Boonipat is a plastic and craniofacial surgeon. His training includes an integrated plastic surgery residency at Mayo Clinic and a craniofacial, maxillofacial, and facial aesthetics fellowship at Chang Gung Memorial Hospital in Taiwan, following medical school at Dartmouth and undergraduate study in biomedical engineering at Johns Hopkins. He founded FacePlus Plastic Surgery Institute in Lubbock in 2024. About FacePlus Plastic Surgery Institute:FacePlus Plastic Surgery Institute is a plastic surgery practice in Lubbock, Texas, founded by Thanapoom Boonipat, MD. The practice provides cosmetic and reconstructive plastic surgery, including facial, breast, and body procedures, serving patients in Lubbock and across West Texas. For more information, visit facepluspsi.com. Media Contact:FacePlus Plastic Surgery Institute [email protected](806) 503-2090 Lubbock, Texas

  4. Miranda Lambert To Kick Off Salvation Army's Red Kettle Campaign With Dallas Cowboys Thanksgiving Game Halftime Performance

    Multi-Platinum, three-time Grammy Award-winning country music superstar Miranda Lambert will perform live at AT&T Stadium during the nationally televised Dallas Cowboys Thanksgiving Day game against the Philadelphia Eagles for the 30th consecutive Salvation Army Red Kettle Kickoff halftime show. The game will air on Fox at 3:30 p.m. CST, shining a spotlight on the needs of millions during the holiday season and throughout the year.

  5. Vantrue Announces Early Black Friday Sale with Up to 44% Off Select Dash Cams

    Vantrue, a dash cam brand dedicated to helping drivers capture the road with confidence, is launching its three-week Black Friday campaign from November 1 to November 21, 2026. The event brings together discounts of up to 44% on selected dash cams, a 100% win-rate prize wheel for subscribers, and exclusive bidding events, giving drivers multiple ways to discover and save on Vantrue products.

  6. Pathway Law Firm Retained to Represent Heir of Levi Brown Following Fatal Shooting at Bakersfield High School Football Game

    Pathway Law Firm has been formally retained to represent the heir of Levi Jermaine Carter Brown, the 17-year-old killed in the August 21, 2026 shooting during the Independence High School–Centennial High School football game in Bakersfield.

  7. Positive Overall Survival Results from the Phase III HARMONi-GI1 Trial of Ivonescimab Plus Chemotherapy Versus Durvalumab Plus Chemotherapy in First-Line Biliary Tract Cancer Presented at the ESMO 2026 Presidential Symposium

    Akeso, Inc. (HKEX: 9926.HK) today announced the presentation of results from the randomized, controlled, double-blind, multicenter, registrational Phase III HARMONi-GI1 trial (AK112-309). The study evaluated first-in-class ivonescimab plus chemotherapy versus durvalumab (PD-L1) plus chemotherapy as first-line treatment for patients with advanced biliary tract cancer (BTC) and was presented at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.

  8. In HelloNation, Insulation Expert Mike Mancuso Explains Why Air Sealing Should Come Before Adding Insulation

    Why should you air seal your home before adding insulation? A HelloNation article featuring insights from Insulation Expert Mike Mancuso of North East Industries in Clarks Summit, Pennsylvania, provides the answer by explaining why air sealing is the first step toward improving comfort, energy performance, and the effectiveness of insulation.

  9. INVESTOR DEADLINE: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline

    $HIMS

    Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between August 4, 2025 and July 29, 2026, all dates inclusive (the "Class Period"), have until Monday, November 2, 2026 to seek appointment as lead plaintiff of the Hims & Hers class action lawsuit.  Captioned Velanki v. Hims & Hers Health, Inc., No. 26-cv-09313 (N.D. Cal.), the Hims & Hers class action lawsuit charges Hims & Hers as well as certain of Hims & Hers' top executives with violations of the Securities Exchange Act of 1934.

  10. Fluence Energy, Inc. (FLNC) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit - Kessler Topaz Meltzer & Check, LLP

    $FLNC

    Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against Fluence Energy, Inc. (Fluence Energy) (NASDAQ: FLNC) on behalf of those who purchased or acquired Fluence Energy securities between November 24, 2025 and September 16, 2026, inclusive. The lawsuit is filed in the United States District Court for the Southern District of New York and is captioned Hatweek v. Fluence Energy, Inc., No. 1:26-cv-08475 (S.D.N.Y.).  Investors have until November 27, 2026, to file for lead plaintiff status.

  11. INVESTOR DEADLINE: Gildan Activewear Inc. Investors with Substantial Losses May Seek to Lead the Gildan Activewear Class Action Lawsuit Before December 14, 2026 Deadline - GIL

    $GIL

    The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Gildan Activewear Inc. (NYSE: GIL) publicly traded securities between February 19, 2025 and June 15, 2026, both dates inclusive (the "Class Period"), have until December 14, 2026 to seek appointment as lead plaintiff of the Gildan Activewear class action lawsuit.  Captioned Cortez v. Gildan Activewear Inc., No. 26-cv-02126 (N.D.N.Y.), the Gildan Activewear class action lawsuit charges Gildan Activewear as well as certain of Gildan Activewear's top current and former executives with violations of the Securities Exchange Act of 1934.

  12. World Young Scientist Summit 2026 Opens in Wenzhou, Zhejiang

    A news report from China Daily:

  13. RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer

    $JNJ

    Johnson & Johnson (NYSE:JNJ) today announced new results from Cohort 5 of the Phase 1b/2 OrigAMI-4 study showing deep and durable responses with first-line subcutaneous amivantamab and hyaluronidase-lpuj plus a PD-1 inhibitor and fixed-duration carboplatin chemotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).1 These findings support the ongoing pivotal Phase 3 OrigAMI-5 study and further expand the clinical development program for subcutaneous amivantamab for patients with head and neck cancer.2

  14. LexisNexis Coplogic Solutions Introduces Field Clarity for LexisNexis® Desk Officer Reporting System (DORS) at IACP 2026

    LexisNexis® Coplogic™ Solutions today announced its modernized LexisNexis® Desk Officer Reporting System (DORS) community online reporting solution and the addition of DORS with Field Clarity, an AI-guided video assistant designed to improve field documentation accuracy and enable faster resolution by law enforcement agencies (LEAs). Field Clarity is designed to help community members submit reports to their local LEAs using DORS via intuitive step-by-step instructions. A hands-on experience for DORS with Field Clarity will be available for demonstration during the 2026 International Association of Chiefs of Police (IACP) annual conference.

  15. ILLR Investors Have Opportunity to Lead Triller Group Inc. Securities Fraud Lawsuit

    $ILLR

    Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Triller Group Inc. (NASDAQ: ILLR) between October 16, 2024 and December 29, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 14, 2026.

  16. QFIN Investors Have Opportunity to Lead Qfin Holdings, Inc. Securities Fraud Lawsuit

    $QFIN

    Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Qfin Holdings, Inc. (NASDAQ: QFIN) between March 18, 2026 and August 25, 2026, inclusive (the "Class Period"), of the important November 30, 2026 lead plaintiff deadline.

  17. Employment & Labor Lawyers, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Lawsuit Against Sinclair Television of California, LLC, for Alleged Failure to Provide Meal Periods and Rest Breaks

    The Sacramento employment law attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, filed a class action complaint alleging that Sinclair Television of California, LLC violated the California Labor Code. The Sinclair Television of California,  LLC class action lawsuit, Case No. 211799, is currently pending in the Shasta County Superior Court of the State of California. A copy of the Complaint can be read here.

  18. BETR Investors Have Opportunity to Lead Better Home & Finance Holding Company Securities Fraud Lawsuit

    $BETR

    BETR Investors Have Opportunity to Lead Better Home & Finance Holding Company Securities Fraud Lawsuit

  19. BAC Investors Have Opportunity to Lead Bank of America Corporation Securities Fraud Lawsuit

    $BAC

    BAC Investors Have Opportunity to Lead Bank of America Corporation Securities Fraud Lawsuit

  20. Bring Your Bunch for Blessings in the Bottoms, Nov. 6-8

    Bring your bunch, count your blessings and get ready to gobble up a weekend of fun. Blessings in the Bottoms returns Nov. 6–8, inviting visitors to celebrate friendship, gratitude and the joy of discovery across 13 blocks of historic warehouses, vintage shops and cobblestone streets.

  21. Monster Energy and Call of Duty® Take Over Cosm Los Angeles for Immersive Modern Warfare® 4 Launch Celebration

    Monster Energy transformed Cosm Los Angeles into the ultimate gamer's destination on Friday night as fans came together to celebrate the highly anticipated launch of Call of Duty®: Modern Warfare® 4 at an immersive event fueled by Monster Energy.

  22. Come Back to Firefox: Mozilla launches its most ambitious campaign yet to bring people back to the independent alternative to big tech browsers

    In its new campaign, Come Back to Firefox, the independent browser by Mozilla reunites personalities behind some of the early internet's biggest viral videos and memes for one simple message: The internet you loved is still here, and Firefox is the easiest way back.

  23. Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, the prespecified final overall survival (OS) analysis results of the Phase III OptiTROP-Lung04 study of sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) were presented as an oral presentation by Professor Wenfeng Fang from the Sun Yat-sen University Cancer Center (LBA67; Proffered paper | NSCLC, Metastatic). The results showed that in patients with epidermal growth factor receptor (EGFR)-mutant locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) who have progressed after treatment with EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy, sac-TMT monotherapy demonstrated a sustained OS benefit compared with platinum-based doublet chemotherapy.

  24. Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, the prespecified final overall survival (OS) analysis results of the Phase III OptiTROP-Lung04 study of sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) were presented as an oral presentation by Professor Wenfeng Fang from the Sun Yat-sen University Cancer Center (LBA67; Proffered paper | NSCLC, Metastatic). The results showed that in patients with epidermal growth factor receptor (EGFR)-mutant locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) who have progressed after treatment with EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy, sac-TMT monotherapy demonstrated a sustained OS benefit compared with platinum-based doublet chemotherapy.

  25. Beyond GRC: DigitalXForce Pioneers AI-Powered Risk Operations with Global X-ROC™ Rollout

    DigitalXForce, the AI-native Enterprise Trust, Risk, Security and Compliance Management (TRiSCM™) platform, today announced the continued global rollout of X-ROC™ (XForce Risk Operations Center), its AI-powered approach to continuous enterprise risk operations.

  26. The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, the results of the Phase III OptiTROP-Lung06 study of sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) were presented as an oral presentation by Professor Caicun Zhou from the Shanghai East Hospital, Tongji University (LBA66; Proffered paper | NSCLC, Metastatic).

  27. The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, the results of the Phase III OptiTROP-Lung06 study of sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) were presented as an oral presentation by Professor Caicun Zhou from the Shanghai East Hospital, Tongji University (LBA66; Proffered paper | NSCLC, Metastatic).

  28. Best AI Tools for Small Business Marketing (2026): CapCut Featured for Creating Professional Video and Visual Content by Expert Consumers

    Expert Consumers has recognized CapCut in its 2026 coverage of the best AI tools for small business marketing, highlighting the platform's collection of AI-powered features for creating and editing video, images, audio, and other visual content. The recognition reflects growing interest in tools that support practical marketing activities, including campaign development, promotional content production, and adapting creative assets for different digital channels.

  29. Borr Drilling Limited - Prospector 5 Rig Incident

    $BORR

    Borr Drilling Limited (NYSE and OSE: BORR) ("Borr Drilling") confirms that an incident occurred at approximately 20:37 local time on October 24, 2026 involving the Prospector 5 drilling rig while conducting jacking operations offshore Gabon in preparation for a planned drilling campaign. The Prospector 5 is owned and operated by Borr Drilling and is contracted to support BW Energy's drilling operations offshore Gabon. Preliminary information indicates that the rig experienced a punch through event during preload activities, resulting in loss of stability and the subsequent sinking of the rig.

  30. Best Broadband Provider for Small Businesses UK (2026): Love Business Group Recognised for Helping SMEs Compare Business Broadband Options by Expert Consumers

    Expert Consumers has recognised Love Business Group for helping small and medium-sized UK businesses compare broadband options based on location, connectivity requirements and day-to-day operational needs. For companies searching for the best broadband provider for UK small businesses, Love Business helps SMEs assess available connection types, contract terms and business broadband features before choosing a suitable service.

  31. Best Protective iPhone Cases for 2026: Top Slim and Drop-Protection Options for iPhone 18 Pro & iPhone 18 Pro Max Recommended by Consumer365

    Consumer365 has recognized TORRAS in its review of the best iPhone cases for 2026, highlighting the Ostand Q3 Air and Ostand Q3 Air Pro as two options designed for iPhone 18 Pro & iPhone 18 Pro Max users seeking a balance between slim everyday usability and impact protection. The review examines documented features including case thickness, weight, grip, raised edges, magnetic support, corner protection, and drop-testing information.

  32. Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule

    $JNJ

    Johnson & Johnson (NYSE:JNJ) today announced promising Phase 1 results for JNJ-6143 (formerly HLD-0915), an investigational once-daily oral Regulated Induced Proximity Targeting Chimera (RIPTAC) small molecule, in patients with advanced prostate cancer who had received multiple prior treatments. Among patients with measurable disease, 75 percent (12 out of 16) had a confirmed complete or partial response assessed by Response Evaluation Criteria in Solid Tumors (RECIST). At the 50 mg dose, 77 percent of patients achieved a confirmed reduction in prostate-specific antigen (PSA) levels of at least 50 percent, and 48 percent had reductions of at least 90 percent. Most treatment-related adverse events were mild to moderate. Data from this study support the selection of the 50-mg once-daily dose for continued clinical development and were presented in a Proffered Paper session at the European Society for Medical Oncology (ESMO) Congress 2026 (#2216O).1

  33. New data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer

    $LLY

    Eli Lilly and Company (NYSE: LLY) today announced new first-line data on olomorasib, its investigational, next-generation KRAS G12C inhibitor, at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain. Results shared in a poster presentation from the Phase 1/2 LOXO-RAS-20001 trial and the safety lead-in portion of the Phase 3 SUNRAY-01 trial of olomorasib plus Merck's anti-PD-1 therapy KEYTRUDA® (pembrolizumab), without chemotherapy, in first-line KRAS G12C-mutant non-small cell lung cancer (NSCLC) show that median progression-free survival (PFS) and duration of response (DOR) had not been reached after a median follow-up of nearly 21 months, with durable activity observed across PD-L1 levels. Separate results in a rapid oral presentation show olomorasib plus chemoimmunotherapy (pembrolizumab, pemetrexed and platinum chemotherapy) achieved an investigator-assessed overall response rate (ORR) of 62% and median DOR of 14.5 months in first-line advanced KRAS G12C NSCLC with a median of nearly 19 months follow up.

  34. Ping An Highlights Green Development Initiatives at International Communication Seminar in Shenzhen Ahead of APEC 2026

    The Seminar on International Communication of Chinese and Foreign Enterprises' Green Development and Global Contributions was held at the Ping An Finance Center in Shenzhen on October 23. Hosted by the China Public Relations Association and co-organized by Ping An Insurance (Group) Company of China, Ltd. ("Ping An" or the "Group"; HKEX: 2318; SSE: 601318), the seminar focused on APEC 2026's three priorities of openness, innovation and cooperation, with discussions also addressing green and sustainable development.

  35. Ping An Highlights Green Development Initiatives at International Communication Seminar in Shenzhen Ahead of APEC 2026

    The Seminar on International Communication of Chinese and Foreign Enterprises' Green Development and Global Contributions was held at the Ping An Finance Center in Shenzhen on October 23. Hosted by the China Public Relations Association and co-organized by Ping An Insurance (Group) Company of China, Ltd. ("Ping An" or the "Group"; HKEX: 2318; SSE: 601318), the seminar focused on APEC 2026's three priorities of openness, innovation and cooperation, with discussions also addressing green and sustainable development.

  36. 2026 ESMO | Innovent Presented Phase 1 Study Data for IBI3001, a First-in-Class EGFR/B7H3 Bispecific ADC

    Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative drugs for major diseases including oncology, autoimmune, metabolic, and ophthalmic diseases, presented for the first time the international Phase 1 clinical data of IBI3001, a first-in-class EGFR/B7H3 ADC, in a Proffered Paper session at the 2026 European Society for Medical Oncology (ESMO) Congress.

  37. 2026 ESMO | Innovent Announcement Phase 2 Data Presentation for IBI354 (HER2 ADC) In First-line Treatment of Breast Cancer

    Innovent Biologics, Inc. (HKEX Stock Code: 01801), a biopharmaceutical company dedicated to the research, development, manufacturing, and commercialization of innovative drugs for major diseases including oncology, autoimmune, metabolic, and ophthalmic diseases, presented for the Phase 2 clinical data of its potential best-in-class IBI354 (HER2 ADC) as first-line treatment for breast cancer (BC) at the 2026 European Society for Medical Oncology (ESMO) Congress.

  38. ST Engineering iDirect and MBSat Partner to Build Next-Generation Sovereign Connectivity Services Across Oman and the Middle East

    ST Engineering iDirect today announced a strategic partnership with Mohammed Al Barwani Satellite Company (MBSat), part of Mohammed Al Barwani Group, to provide the ground system technology foundation for MBSat's next-generation satellite gateway and network operations across Oman and the wider Middle East region. Intuition will provide a flexible, software-defined foundation to support sovereign connectivity services, enabling efficient service deployment, dynamic resource management and scalable network operations.

  39. ST Engineering iDirect and MBSat Partner to Build Next-Generation Sovereign Connectivity Services Across Oman and the Middle East

    ST Engineering iDirect today announced a strategic partnership with Mohammed Al Barwani Satellite Company (MBSat), part of Mohammed Al Barwani Group, to provide the ground system technology foundation for MBSat's next-generation satellite gateway and network operations across Oman and the wider Middle East region. Intuition will provide a flexible, software-defined foundation to support sovereign connectivity services, enabling efficient service deployment, dynamic resource management and scalable network operations.

  40. Zhejiang Wenda Pharma Announces Positive Results from Phase II Trial of Oral BET Inhibitor NHWD-870 HCl at the 2026 ESMO Annual Meeting

    At the 2026 ESMO Annual Meeting, Zhejiang Wenda Pharmaceutical Technology Co., Ltd. ("Wenda Pharma")  will publish the phase II clinical trial data for NHWD-870 HCl, an oral BET inhibitor, in Chinese patients with advanced NUT carcinoma (NC).

  41. Flotek Deadline: FTK Investors Have Opportunity to Lead Flotek Industries, Inc. Securities Fraud Lawsuit

    $FTK

    Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Flotek Industries, Inc. (NYSE: FTK) between August 3, 2026 and August 17, 2026, both dates inclusive (the "Class Period"), of the important October 26, 2026 lead plaintiff deadline.

  42. Herman Law Client Survivors Reach Landmark Settlement With Archdiocese of New York

    Herman Law, representing approximately 260 survivors of sexual abuse by clergy members and lay leaders of the Archdiocese of New York, the second largest group of plaintiffs in the case, announced today that a settlement has been reached resolving claims brought by more than 1,300 survivors against the Archdiocese.

  43. HYLN Deadline: HYLN Investors Have Opportunity to Lead Hyliion Holdings Corp. Securities Fraud Lawsuit

    $HYLN

    Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Hyliion Holdings Corp. (NYSE American: HYLN) between May 12, 2026 and June 23, 2026, both dates inclusive (the "Class Period"), of the important October 27, 2026 lead plaintiff deadline.

  44. NCPL Investors Have Opportunity to Lead Netcapital Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm

    $NCPL

    Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Netcapital Inc. (NASDAQ: NCPL) between December 15, 2021 and September 3, 2026, both dates inclusive (the "Class Period"), of the important December 7, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

  45. CARNE Brings a Nightmare Before Christmas to Oxnard with Limited-Time Halloween Pop-Up

    CARNE in Oxnard invites guests into a world where spooky meets delicious with A Nightmare at CARNE, a limited-time Halloween pop-up running through November 1, 2026.

  46. Siegal & Richardson Announces Civil Rights Lawsuit Filed Against Historic Marin County Bar

    Siegal & Richardson, a Berkeley-based law firm, announces a civil rights lawsuit on behalf of John Kruger, 66, a longtime Northern California entrepreneur and founder of GCX, against the Silver Peso, a historic neighborhood bar in Larkspur, California.

  47. INV Deadline: INV Investors Have Opportunity to Lead Innventure, Inc. Securities Fraud Lawsuit

    $INV

    Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Innventure, Inc. (NASDAQ: INV) between November 17, 2025 and August 13, 2026, both dates inclusive (the "Class Period"), of the important October 27, 2026 lead plaintiff deadline.

  48. Rosen Law Firm Encourages Yiren Digital Ltd. Investors to Inquire About Securities Class Action Investigation - YRD

    $YRD

    Rosen Law Firm Encourages Yiren Digital Ltd. Investors to Inquire About Securities Class Action Investigation - YRD

  49. Roadrunner Launches Its First-Ever Outbound Canada-to-U.S. LTL Service, Connecting Key Canadian Markets to 40+ U.S. Metropolitan Areas via Its Smart Network™

    Roadrunner, the most tech-forward carrier in LTL, today launched its first-ever outbound Canada-to-United States LTL service, giving Canadian shippers seamless, direct access to the entire country through its proprietary Smart Network™, which spans more than 40 metropolitan areas across the U.S. To keep investing in the network that makes service like this possible, the company also announced an overall general rate increase (GRI) of 5.9% applicable to its RDFS 501 and RDFS 1000 base rates, effective November 2, 2026.

Source: PR Newswire

Content provided by PR Newswire. Redistribution, resale or sublicensing is not permitted.

    PR Newswire press releases | Signal8